4Tmleber FR. Bslkwill: Regulation of monocyte MMP-9 production by TNF-α and a tumour derived souble factor (MMPsF). Brtish Journal of Cancer, 1998,78.. 724-732.
5Greene J, Wang M, Liu YE, et al. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase-4. J Biol Chem, 1996,271 : 30375-30380.
6Kmowlden J, Martin J, Davies M. Metalloproteinase generation by human glomerular epithelial cells. Kidney Int, 1995,47:1682-1689.
7Yoshiji H, Gomez DE, Thorgeirsson UP.Enhanced RNA expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in human breast Int. Cancer(Pred. Oncol), 1996, 69:131-134.
8Baricos WH, Crotez SL, Dahr SS, et al.ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Kidney Int, 1995, 47:1039-1047.
9Maxwell PR, Timnis PM, Chandrant S, et al. Peripheral blood level alteration of TIMP-1, MMP-2 and MMP-9 in patients with type ldiabetes. Diabetes UK Diabetic Medicine, 2001,18: 777-780.
10Wu K, Setty S, Mailer SM, et al. Altered kidney matrix gene expression in early stages of experimental diabetes. Acta Anat, 1997,158:155-165.
二级参考文献3
1Dr. J. T. Tamsma,J. Born,J. A. Bruijn,K. J. M. Assmann,J. J. Weening,J. H. M. Berden,J. Wieslander,E. Schrama,J. Hermans,J. H. Veerkamp,H. H. P. J. Lemkes,F. J. Woude. Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane[J] 1994,Diabetologia(3):313～320
7Leehey DJ,Singh A K,Alavi N,et al.Role of angiotensin Ⅱ in diabetic nephropathy[J]. Kidney Int,2000,[Suppl 58]:93-98.
8Wolf G.Link between angiotensin Ⅱand TGF-β in the kidney.Miner Electrolyte Metab,1998,24(2-3):174-178.
9Border WA,Noble NA.Effect of maximal reduction of angiotensin in renal fibresis:bad news-good news form a pediatric mouse[J].Am J Kidney Dis,2000,35(4):773-776.
10Goto H ,wakui H ,Komatsuda A ,et al.Renal alpha-actinin-4:purification and puromycin aminonucleoside-binding property[J].Nephron Exp Nephol,2003,93(1):e27-e35.
